Published in Virology on February 01, 1980
Poxvirus pathogenesis. Microbiol Rev (1991) 3.54
Fusion of intra- and extracellular forms of vaccinia virus with the cell membrane. J Virol (1990) 3.18
Isolation and characterization of neutralizing monoclonal antibodies to vaccinia virus. J Virol (1985) 3.06
A 14,000-Mr envelope protein of vaccinia virus is involved in cell fusion and forms covalently linked trimers. J Virol (1987) 2.53
Location of DNA-binding proteins and disulfide-linked proteins in vaccinia virus structural elements. J Virol (1984) 1.38
A vaccinia virus core protein, p39, is membrane associated. J Virol (1996) 1.37
Identification of the orthopoxvirus p4c gene, which encodes a structural protein that directs intracellular mature virus particles into A-type inclusions. J Virol (2002) 1.14
Two distinct low-pH steps promote entry of vaccinia virus. J Virol (2007) 1.13
Insertional inactivation of the vaccinia virus 32-kilodalton gene is associated with attenuation in mice and reduction of viral gene expression in polarized epithelial cells. J Virol (1992) 1.10
The 32-kilodalton envelope protein of vaccinia virus synthesized in Escherichia coli binds with specificity to cell surfaces. J Virol (1991) 0.99
Vaccinia virus preferentially enters polarized epithelial cells through the basolateral surface. J Virol (1991) 0.97
Effect of glycosylation inhibitors on the release of enveloped vaccinia virus. J Virol (1982) 0.93
Biogenesis of poxviruses: role of A-type inclusions and host cell membranes in virus dissemination. Virology (1971) 3.57
Biogenesis of poxviruses: interrelationship between hemagglutinin production and polykaryocytosis. Virology (1971) 2.06
Neutralizing epitope on penetration protein of vaccinia virus. Virology (1996) 1.75
N-terminal amino acid sequences of vaccinia virus structural proteins. Virology (1994) 1.71
Hemadsorption and fusion inhibition activities of hemagglutinin analyzed by vaccinia virus mutants. Virology (1990) 1.58
Location of DNA-binding proteins and disulfide-linked proteins in vaccinia virus structural elements. J Virol (1984) 1.38
Characterization of vaccinia polypeptides. Virology (1981) 1.26
Identification of a vaccinia virus penetration protein. Virology (1994) 1.11
Human T-cell leukemia virus type 1 tax protein activates transcription through AP-1 site by inducing DNA binding activity in T cells. Virology (2001) 1.09
Epitope mosaic on the surface proteins of orthopoxviruses. Virology (1988) 1.05
Unit Complex of vaccinia polypeptides linked by disulfide bridges. Virology (1981) 1.02
Changes in ocular astigmatism over the whole range of accommodation. Optom Vis Sci (1991) 1.01
Proteolytic activation of vaccinia virus for the penetration phase of infection. Virology (1982) 1.01
Vaccinia-specific hemagglutinin. Virology (1977) 1.01
Subclass of IgG antibody to GM1 epitope-bearing lipopolysaccharide of Campylobacter jejuni in patients with Guillain-Barré syndrome. J Neuroimmunol (1995) 0.99
Modification of vaccinia virus penetration proteins analyzed by monoclonal antibodies. Virology (1987) 0.97
The activation of vaccinia virus infectivity by the transfer of phosphatidylserine from the plasma membrane. Virology (1983) 0.96
The effect of proteolytic enzymes on the infectivity of vaccinia virus. Virology (1982) 0.96
The function of the vaccinia hemagglutinin in the proteolytic activation of infectivity. Virology (1990) 0.95
Reversible inactivation and reactivation of vaccinia virus by manipulation of viral lipid composition. Virology (1985) 0.87
Studies on the nature of Marchal bodies (A-type inclusion) during ectromelia virus infection. Virology (1966) 0.87
Activation of oncogenic transcription factor AP-1 in T cells infected with human T cell leukemia virus type 1. AIDS Res Hum Retroviruses (2000) 0.86
Positive symptoms and duration of illness predict functional laterality and attention modulation in schizophrenia. Acta Psychiatr Scand (2006) 0.84
The relationship between poxvirus and A-type inclusion body during double infection. Virology (1968) 0.83
Backward-masking deficit in adolescents with schizophrenic disorders or attention deficit hyperactivity disorder. Am J Psychiatry (1996) 0.82
Characterization of metal ion-implanted titanium oxide photocatalysts operating under visible light irradiation. J Synchrotron Radiat (1999) 0.80
Target antigen of vaccinia-infected cells recognized by virus-specific cytotoxic T lymphocytes. Microbiol Immunol (1981) 0.79
No vigilance deficit found in either young schizophrenic or ADHD subjects. Scand J Psychol (1998) 0.79
Biogenesis of poxviruses: relationship between a translation complex and formation of A-type inclusions. Virology (1973) 0.78
A morphological study in germfree mice (Salmonella infection). Exp Pathol (Jena) (1979) 0.78
Interleukin-2-dependent but not independent T-cell lines infected with human T-cell leukemia virus type 1 selectively express CD45RO, a marker for persistent infection in vivo. Virus Genes (2001) 0.78
Toxic haloperidol reactions with observation of serum haloperidol concentration in two children. Dev Pharmacol Ther (1982) 0.78
Homovanillic acid, vanillylmandelic acid and 5-hydroxyindole-3-acetic acid are undetectable in urine of the muskrat. Chem Pharm Bull (Tokyo) (1985) 0.77
Application of ion beam techniques for preparation of metal ion-implanted TiO2 thin film photocatalyst available under visible light irradiation: metal ion-implantation and ionized cluster beam method. J Synchrotron Radiat (2001) 0.76
IgM anti-(GalNAc beta 1-4 Gal[3-2 alpha NeuAc] beta 1-) antibody-mediated cytotoxicity in a patient with amyotrophic lateral sclerosis-like disorder. Muscle Nerve (1992) 0.76
Expressed emotion, communication deviance and schizophrenia. An exploratory study of the relationship between two family variables and the course and outcome of a psychoeducational treatment programme. Psychopathology (1995) 0.76
A-type inclusion markers of wild white and other variola-related poxviruses. Jpn J Med Sci Biol (1976) 0.75
Span of apprehension in adolescents with schizophrenia or ADHD. Schizophr Res (1999) 0.75
Effects of antibiotics on platelet aggregation. Drugs (1988) 0.75
[Experience with cefuroxime in pediatric field (author's transl)]. Jpn J Antibiot (1979) 0.75
[Fundamental and clinical studies of cefotiam in the field of pediatrics (author's transl)]. Jpn J Antibiot (1981) 0.75
[The experimental and clinical studies on cefsulodin in the pediatric field]. Jpn J Antibiot (1982) 0.75
[Study of cefroxadine in pediatrics regarding clinical efficacy and serum levels (author's transl)]. Jpn J Antibiot (1981) 0.75
[Criteria for selection of the first, second and third generation cephem antibiotics. 3. Pediatrics]. Nihon Rinsho (1984) 0.75
[Evaluation of blood concentrations and audiometric responses following administration of tobramycin in newborn infants--the brain stem auditory response]. Kansenshogaku Zasshi (1982) 0.75
[Fundamental and clinical studies of cefotaxime in neonates and immature infants]. Jpn J Antibiot (1982) 0.75
[Basic and clinical evaluation of ceftezole (Celoslin) intravenous drip infusion in pediatric field (author's transl)]. Jpn J Antibiot (1980) 0.75
[Basic and clinical examinations of CS-1170 in pediatrics (author's transl)]. Jpn J Antibiot (1979) 0.75
Determination of homovanillic acid in human plasma by high-performance liquid chromatography with electrochemical detection. J Chromatogr (1985) 0.75
[Fundamental and clinical evaluation of 9,3"-diacetylmidecamycin in pediatric field (author's transl)]. Jpn J Antibiot (1982) 0.75
[Colonization of bacteria in man]. Nihon Ishikai Zasshi (1972) 0.75
[Fundamental and clinical studies of tobramycin by intravenous drip infusion in pediatric field (author's transl)]. Kansenshogaku Zasshi (1981) 0.75
Empowerment through collaboration: implementing a team quality assurance model. J Nurs Care Qual (1992) 0.75
Relationship between the stability of intestinal bacterial flora and several antibiotics; erythromycin, colimycin etc. Keio J Med (1966) 0.75
[Processing of vaccinia genome terminal: initiation of DNA synthesis and concatemer resolution]. Tanpakushitsu Kakusan Koso (1992) 0.75
[Effects of pantethine on proliferation of intestinal bifidus bacteria in bottle-fed infants]. Nihon Shonika Gakkai Zasshi (1971) 0.75
[Examination of blood levels and urinary excretion of cefmetazole in the mature and immature neonates (author's transl)]. Jpn J Antibiot (1981) 0.75
[Infections caused by gram-negative bacillus]. Nihon Ishikai Zasshi (1967) 0.75
[Basic and clinical examinations of 6059-S in pediatrics (author's transl)]. Jpn J Antibiot (1981) 0.75
[Evaluation of intravenous injection of cephalothin to new-born babies (author's transl)]. Jpn J Antibiot (1977) 0.75
[Comparison of kinetics and effectiveness against pseudomonas aeruginosa between intravenously and intramuscularly administered tobramycin; experimental study using diffusion chambers incubated in rabbit's peritoneal cavity (author's transl)]. Kansenshogaku Zasshi (1981) 0.75
[Clinical investigation of cefadroxil in pediatric field (author's transl)]. Jpn J Antibiot (1981) 0.75
[A study of serum levels of cefazolin following a single intravenous dose in newborns, immature infants and younger children (author's transl)]. Jpn J Antibiot (1980) 0.75
Application of total quality management to unit-based quality assessment and improvement. J Nurs Care Qual (1994) 0.75
[Effect of i.v. immunoglobulins on experimental infections--especially in combination with antibiotics]. Kansenshogaku Zasshi (1982) 0.75
[Pharmacokinetics study on gentamicin intravenous drip infusion in children]. Jpn J Antibiot (1983) 0.75
Autonomous staff selection teams. J Nurs Adm (1992) 0.75
A Creutzfeldt-Jakob disease agent (Echigo-1 strain) recovered from brain tissue showing the 'panencephalopathic type' disease. Neurology (1989) 0.75
Functional differences between the external and protoplasmic surfaces of plasma membranes in activating vaccinia virus infectivity. Virology (1982) 0.75
[Basic and clinical studies on cefmenoxime in pediatric field]. Jpn J Antibiot (1982) 0.75
[Fundamental and clinical studies of PC-904 in pediatrics (author's transl)]. Jpn J Antibiot (1978) 0.75